Peptide Receptor Radionuclide Therapy: An Overview-Reference-Cited by-同舟云学术

Peptide Receptor Radionuclide Therapy: An Overview

Published:2015-03 Issue:2 Volume:30 Page:47-71
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Dash Ashutosh¹,Chakraborty Sudipta¹,Pillai Maroor Raghavan Ambikalmajan²,Knapp Furn F. (Russ)³

Affiliation:

1. Isotope Production and Applications Division, Bhabha Atomic Research Centre, Mumbai, India.

2. Molecular Group of Companies, Kochi, India.

3. Medical Isotopes Program, Isotope Development Group, Oak Ridge National Laboratory (ORNL), Oak Ridge, Tennessee.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2014.1741

Reference218 articles.

1. Radionuclide therapy

2. Physical and Biological Targeting of Radiotherapy

3. Systemic radiation therapy with unsealed radionuclides

4. Therapeutic Radiopharmaceuticals

5. Towards the goal of cancer-specific imaging and therapy

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative SPECT/CT Metrics in Early Prediction of [¹⁷⁷Lu]Lu-DOTATATE Treatment Response in Gastroenteropancreatic Neuroendocrine Tumor Patients;Journal of Nuclear Medicine;2024-09-12

2. Can current preclinical strategies for radiopharmaceutical development meet the needs of targeted alpha therapy?;European Journal of Nuclear Medicine and Molecular Imaging;2024-04-27

3. Preclinical Characterization of DPI-4452: A⁶⁸Ga/¹⁷⁷Lu Theranostic Ligand for Carbonic Anhydrase IX;Journal of Nuclear Medicine;2024-03-21

4. First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX–Targeting Peptide, [⁶⁸Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma;Journal of Nuclear Medicine;2024-02-22

5. Peptide-Drug Conjugates: Design, Chemistry, and Drug Delivery System as a Novel Cancer Theranostic;ACS Pharmacology & Translational Science;2024-01-24